Regulators Intensify Scrutiny of Compounded GLP-1 Advertising as Industry Grows
Advertising for compounded GLP-1 weight loss products is facing increased scrutiny as regulators respond to the rapid expansion of telehealth ...
Read MoreEli Lilly Seeks FDA Approval for Oral GLP-1 After Maintenance Trial Results
If you have ever followed GLP-1 news, you have probably noticed the same pattern that shows up again and again. ...
Read MoreProRx Under FDA Scrutiny: What the Warning Letter and Recall Mean
ProRx has recently come under FDA scrutiny following an inspection of its facility and the publication of an FDA Warning ...
Read More